Cannabis Bioscience International Holdings reported total assets of $0.00M and total liabilities of $1.47M for the quarter ended Feb 2026, down 89.6% year over year. This balance sheet covers 14 quarters of results from Nov 2022 through Feb 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Nov2022 | Feb2023 | May2023 | Aug2023 | Nov2023 | Feb2024 | May2024 | Aug2024 | Nov2024 | Feb2025 | May2025 | Aug2025 | Nov2025 | Feb2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.02M | 0.03M | 0.01M | 0.00M | 337.00 | 794.00 | 755.00 | 969.00 | 0.00M | 548.00 | 0.01M | 223.00 | 132.00 | 90.00 |
| Cash & Current Investments | 0.02M | 0.03M | 0.01M | 0.00M | 337.00 | 794.00 | 755.00 | 969.00 | 0.00M | 548.00 | 0.01M | 223.00 | 132.00 | 90.00 |
| Receivables - NetNet Receivables | 0.01M | 0.02M | 0.02M | 0.02M | 0.02M | 0.01M | 0.00M | 0.01M | 0.01M | 0.02M | 0.00M | |||
| Receivables - OtherOther Receivables | 0.01M | 0.01M | ||||||||||||
| Receivables | 0.01M | 0.02M | 0.02M | 0.02M | 0.02M | 0.01M | 0.00M | 0.02M | 0.02M | 0.02M | 0.00M | |||
| Prepaid Assets | 598.00 | 598.00 | 598.00 | 598.00 | 598.00 | 598.00 | 598.00 | 598.00 | 188.00 | 188.00 | ||||
| Current Assets | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.00M | 0.03M | 0.02M | 0.02M | 0.00M | |||
| Non-Current Assets | ||||||||||||||
| Non-Current Assets | 0.02M | 0.08M | 0.08M | 0.04M | 0.03M | 0.02M | 0.01M | 0.00M | ||||||
| Assets | 0.04M | 0.10M | 0.09M | 0.06M | 0.05M | 0.03M | 0.01M | 0.03M | 0.02M | 0.02M | 0.00M | |||
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payables | 0.11M | 0.21M | 0.26M | 0.17M | 0.14M | 0.17M | 0.15M | 0.10M | 0.10M | 0.16M | 0.19M | |||
| Notes Payables | 0.12M | 0.15M | 0.15M | 0.14M | 0.11M | 0.11M | 0.12M | 0.11M | 0.11M | 0.11M | 0.11M | |||
| Payables | 0.23M | 0.36M | 0.41M | 0.30M | 0.25M | 0.28M | 0.28M | 0.21M | 0.21M | 0.27M | 0.30M | |||
| Accumulated Expenses | 0.02M | 0.02M | 0.03M | 0.03M | ||||||||||
| Short term Debt | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | |||
| Current Leases | 0.00M | 0.00M | 0.06M | 0.02M | 0.02M | 0.02M | 0.01M | 0.00M | ||||||
| Current Deferred Revenue | 0.03M | 0.01M | ||||||||||||
| Total Current Liabilities | 0.39M | 0.66M | 0.80M | 0.88M | 0.85M | 0.87M | 0.97M | 0.95M | 1.02M | 1.14M | 1.22M | |||
| Non-Current Liabilities | ||||||||||||||
| Non-Current Debt | 0.25M | 0.25M | 0.25M | 0.25M | 0.25M | 0.25M | 0.25M | 0.25M | 0.25M | 0.25M | 0.25M | |||
| Operating Leases | 0.00M | 0.02M | 0.03M | 0.02M | 0.02M | 0.01M | 0.00M | |||||||
| Total Non-Current Liabilities | 0.25M | 0.28M | 0.27M | 0.25M | 0.25M | 0.33M | 0.27M | 0.25M | 0.25M | 0.25M | 0.25M | |||
| Total Liabilities | 0.41M | 0.48M | 0.64M | 0.72M | 0.94M | 1.07M | 1.14M | 1.10M | 1.20M | 1.24M | 1.20M | 1.27M | 1.39M | 1.47M |
| Shareholder's Equity | ||||||||||||||
| Total Debt | 0.39M | 0.41M | 0.41M | 0.39M | 0.37M | 0.38M | 0.39M | 0.38M | 0.38M | 0.38M | 0.38M | |||
| Common Equity | -0.41M | -0.48M | -0.59M | -0.72M | -0.84M | -0.98M | -1.08M | -1.06M | -1.13M | -1.23M | -1.16M | -1.25M | -1.36M | -1.47M |
| Liabilities and Shareholders Equity | 0.04M | 0.10M | 0.09M | 0.06M | 0.05M | 0.03M | 0.01M | 0.03M | 0.02M | 0.02M | 0.00M | |||
| Retained Earnings | -4.68M | -5.20M | -5.20M | -5.33M | -5.41M | -5.49M | -5.67M | -5.88M | -5.97M | -6.08M | -6.19M |